Why was the database created?
The aim of this registry is to assess the safety and effectiveness of the implantation of artificial aortic valves (bioprostheses) implanted via a trans-arterial or trans-apical approach, as well as long-term outcomes.
What data does the database contain?
- Population of interest
- Patients who have undergone aortic valve bioprosthesis implantation via a trans-arterial or trans-apical approach in one of the participating healthcare facilities.
- Age group
- Older adult (65 and over) Adult (18 to 64)
- Data category
- Identification data (not directly identifying) Medical and administrative data Directly identifying data Quality of life Socio-professional data Clinical data
- Data collection methods
- eCRF
How is the data managed?
- Data retention period
- The data will be kept until 2025 for analysis as part of research projects, and will then be archived for a period of 10 years.
Why is the database legal?
- Data controller
- Société Française de Cardiologie
- Legal basis
- The processing carried out by the SFC is necessary for the performance of the task carried out in the public interest with which it is entrusted. This processing is therefore lawful under Article 6-1-e) of the GDPR and meets a condition allowing the processing of data concerning health under Article 9-2-i) of the GDPR.
- Data quality and completion
- Clinical data are collected directly from patients by physicians or under their supervision, ensuring a first level of quality. A consistency check of these data is carried out under the supervision of the SFC. SNDS data are updated on an annual basis. A data preparation pipeline is used to perform data quality work, including in particular ensuring their consistency.
- Data transfer outside the EU
- The data are collected through an observation logbook hosted by IBM Cloud. These data are processed within the European Union. Maintenance operations on this platform are carried out by IBM teams located in the European Union. In exceptional cases where the European teams are unable to resolve a technical issue, access may be granted to IBM teams located outside the European Union solely for the purposes of this maintenance. In such a situation, IBM undertakes to comply with data protection rules equivalent to European regulations, in accordance with the standard contractual clauses issued by the European Commission.
Research projects powered by France TAVI
France TAVI - Événements coronariens après implantation de valve aortique transcathéter : perspectives du registre France TAVI
Completed
Read more →
France TAVI - Incidence, facteurs prédictifs et résultats à long terme de la réintervention après implantation de valve aortique transcathéter
Completed
Read more →
France TAVI - résultats de l'implantation de valve aortique transcathéter pour la régurgitation de la valve aortique native
Completed
Read more →
France TAVI - Évaluation des résultats cliniques des TAVI Valve in valve à long terme, selon le type de prothèse et chez les patients à bas risques
Analysis in progress
Read more →
France TAVI - Effets cliniques de l'implantation d'un Pacemaker permanent après une implantation de valve aortique transcathéter
Completed
Read more →
France TAVI - ML - Prédiction de la mortalité en hôpital après TAVI : une approche Machine Learning
Recruitment in progress
Read more →
France TAVI - Score AVC - Un score de risque clinique pour prédire l'AVC ischémique précoce après TAVI
Analysis in progress
Read more →
France TAVI - QOL - Mauvais pronostic après TAVI en utilisant l'EQ 5D 5L
Follow-up in progress
Read more →
France TAVI - Evaluation de l’intérêt d’un remplacement valvulaire aortique par TAVI avant une chirurgie non cardiaque
Not started
Read more →